Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000086179 | SCV001245804 | pathogenic | not provided | 2021-09-01 | criteria provided, single submitter | clinical testing | |
Institute of Medical Molecular Genetics, |
RCV000002854 | SCV001548103 | likely pathogenic | Vitelliform macular dystrophy 2 | 2021-01-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000086179 | SCV001580917 | pathogenic | not provided | 2023-03-11 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this variant affects BEST1 function (PMID: 17898294). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. ClinVar contains an entry for this variant (Variation ID: 2733). This variant has been observed in individuals with Best vitelliform macular dystrophy (PMID: 9700209, 16612637). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This variant, c.884_886del, results in the deletion of 1 amino acid(s) of the BEST1 protein (p.Ile295del), but otherwise preserves the integrity of the reading frame. |
MGZ Medical Genetics Center | RCV000002854 | SCV002580310 | likely pathogenic | Vitelliform macular dystrophy 2 | 2021-09-15 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000002854 | SCV000023012 | pathogenic | Vitelliform macular dystrophy 2 | 1998-09-01 | no assertion criteria provided | literature only | |
Retina International | RCV000086179 | SCV000118323 | not provided | not provided | no assertion provided | not provided |